• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013年腹膜透析登记处调查报告

Peritoneal Dialysis Registry With 2013 Survey Report.

作者信息

Masakane Ikuto, Hasegawa Takeshi, Ogata Satoshi, Kimata Naoki, Nakai Shigeru, Hanafusa Norio, Hamano Takayuki, Wakai Kenji, Wada Atsushi, Nitta Kosaku

机构信息

Statistical Survey Committee, Japanese Society for Dialysis Therapy, Japan.

Subcommittee of Statistical Analysis, Japanese Society for Dialysis Therapy, Japan.

出版信息

Ther Apher Dial. 2016 Dec;20(6):557-568. doi: 10.1111/1744-9987.12520.

DOI:10.1111/1744-9987.12520
PMID:28033679
Abstract

Since 2009, the peritoneal dialysis (PD) registry has been carried out as part of the annual nationwide survey conducted by the Statistical Survey Committee of the Japanese Society for Dialysis Therapy with the cooperation of the Japanese Society for Peritoneal Dialysis. In this study, the current status of PD patients is reported on the basis of the results of the survey conducted at the end of 2013. The subjects were PD patients who lived in Japan and participated in the 2013 survey. Descriptive analysis was performed for various items including the current status of the combined use of PD and another dialysis method such as hemodialysis (HD) or hemodiafiltration (HDF), the method of exchanging dialysate, the use of an automated peritoneal dialysis (APD) machine, and the incidences of peritonitis and catheter exit-site infection. From the results of the facility survey in 2013, the number of PD patients was 9392, a decrease of 122 from that in 2012. Among the entire dialysis patient population, 3.0% were PD patients, a decrease of 0.1%. Among the studied patients, 292 had a peritoneal catheter and underwent peritoneal lavage, 174 were started on PD in 2013 but introduced to other blood purification methods in 2013, and 1920 underwent both PD and another dialysis method such as HD or HDF. The percentage of patients who underwent PD and another dialysis method increased with the number of years on PD: <1 year, 3.5%; 1 to < 2 years, 8.4%; 2 to < 4 years, 15.3%; 4 to < 6 years, 27.1%; 6 to < 8 years, 39.3%; 8 to < 10 years, 47.1%; and ≥ 10 years, 57.5%. The percentage of PD patients for whom the dialysate was completely manually exchanged was 31.6%, whereas the percentages of PD patients who used a bag-exchange device based on ultraviolet-light irradiation and that based on thermal sterile joint systems were 52.1 and 14.9%, respectively. The mean incidence of peritonitis was 0.22 per patient per year (once per 54.5 patients per month). The mean incidence of catheter exit-site infection was 0.34 per patient per year (once per 35.3 patients per month).

摘要

自2009年起,腹膜透析(PD)登记作为日本透析治疗学会统计调查委员会在日本腹膜透析学会合作下开展的年度全国性调查的一部分进行。在本研究中,根据2013年底进行的调查结果报告了PD患者的现状。研究对象为居住在日本并参加2013年调查的PD患者。对包括PD与血液透析(HD)或血液透析滤过(HDF)等其他透析方法联合使用的现状、透析液交换方法、自动腹膜透析(APD)机的使用情况以及腹膜炎和导管出口处感染的发生率等各项指标进行了描述性分析。根据2013年机构调查结果,PD患者人数为9392人,比2012年减少了122人。在整个透析患者群体中,PD患者占3.0%,下降了0.1%。在研究患者中,292人有腹膜导管并接受了腹膜灌洗,174人于2013年开始接受PD治疗,但在2013年改用其他血液净化方法,1920人同时接受了PD和HD或HDF等其他透析方法。接受PD和其他透析方法的患者比例随着PD治疗年限的增加而上升:<1年,3.5%;1至<2年,8.4%;2至<4年,15.3%;4至<6年,27.1%;6至<8年,39.3%;8至<10年,47.1%;≥10年,57.5%。透析液完全手动交换的PD患者比例为31.6%,而使用基于紫外线照射的袋式交换装置和基于热无菌连接系统的袋式交换装置的PD患者比例分别为52.1%和14.9%。腹膜炎的平均发生率为每年每位患者0.22次(每月每54.5名患者发生1次)。导管出口处感染的平均发生率为每年每位患者0.34次(每月每35.3名患者发生1次)。

相似文献

1
Peritoneal Dialysis Registry With 2013 Survey Report.2013年腹膜透析登记处调查报告
Ther Apher Dial. 2016 Dec;20(6):557-568. doi: 10.1111/1744-9987.12520.
2
Peritoneal Dialysis Registry With 2012 Survey Report.2012年腹膜透析登记处调查报告
Ther Apher Dial. 2015 Dec;19(6):529-39. doi: 10.1111/1744-9987.12382.
3
An overview of regular dialysis treatment in Japan (as of 31 December 2012).日本常规透析治疗概况(截至2012年12月31日)。
Ther Apher Dial. 2014 Dec;18(6):535-602. doi: 10.1111/1744-9987.12281.
4
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).日本常规透析治疗概述(截至2013年12月31日)
Ther Apher Dial. 2015 Dec;19(6):540-74. doi: 10.1111/1744-9987.12378.
5
Outcome and complications in peritoneal dialysis patients: a five-year single center experience.腹膜透析患者的结局与并发症:一项为期五年的单中心经验
Saudi J Kidney Dis Transpl. 2011 Mar;22(2):245-51.
6
[Results of the cooperative study of Spanish peritoneal dialysis registries: analysis of 12 years of follow-up].[西班牙腹膜透析登记合作研究结果:12年随访分析]
Nefrologia. 2014;34(1):18-33. doi: 10.3265/Nefrologia.pre2013.Jul.12106.
7
Present status and future of peritoneal dialysis in Japan.日本腹膜透析的现状与未来。
Contrib Nephrol. 2015;185:116-23. doi: 10.1159/000380975. Epub 2015 May 19.
8
Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry.日本东海地区腹膜透析现状与结局的近期分析:东海腹膜透析登记处的第二次报告
Clin Exp Nephrol. 2016 Dec;20(6):960-971. doi: 10.1007/s10157-016-1249-9. Epub 2016 Mar 7.
9
Overview of regular dialysis treatment in Japan (as of 31 December 2005).日本定期透析治疗概况(截至2005年12月31日)。
Ther Apher Dial. 2007 Dec;11(6):411-41. doi: 10.1111/j.1744-9987.2007.00523.x.
10
The 1997 Report of the Japanese National Registry data on pediatric peritoneal dialysis patients.1997年日本全国小儿腹膜透析患者登记数据报告。
Perit Dial Int. 1999;19 Suppl 2:S473-8.

引用本文的文献

1
Effect of proactive combination therapy with peritoneal dialysis and hemodialysis on technique survival and mortality.主动联合腹膜透析和血液透析治疗对技术生存率和死亡率的影响。
J Artif Organs. 2024 Dec;27(4):429-434. doi: 10.1007/s10047-024-01437-z. Epub 2024 Mar 22.
2
Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis.腹膜透析患者中钙、磷和完整甲状旁腺激素水平与死亡率、残余肾功能及技术失败的相关性
Clin Kidney J. 2023 Sep 7;16(11):1957-1964. doi: 10.1093/ckj/sfad223. eCollection 2023 Nov.
3
Sustainability of peritoneal dialysis and renal function with proactive combination therapy.
主动联合治疗对腹膜透析和肾功能的可持续性。
J Artif Organs. 2023 Dec;26(4):335-339. doi: 10.1007/s10047-022-01375-8. Epub 2022 Dec 6.
4
Predictive Factors, Treatment, and Outcomes of Coagulase-Negative Staphylococcal Peritonitis in Malaysian Peritoneal Dialysis Patients: A Single-Center Study.马来西亚腹膜透析患者凝固酶阴性葡萄球菌性腹膜炎的预测因素、治疗及结局:一项单中心研究
Int J Nephrol. 2022 Apr 11;2022:8985178. doi: 10.1155/2022/8985178. eCollection 2022.
5
Combination of once-weekly haemodialysis with peritoneal dialysis is associated with lower mortality compared with peritoneal dialysis alone: a longitudinal study.一项纵向研究表明,每周一次血液透析与腹膜透析联合治疗相比单独腹膜透析死亡率更低。
Clin Kidney J. 2020 Nov 7;14(6):1610-1617. doi: 10.1093/ckj/sfaa173. eCollection 2021 Jun.
6
Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients.达普司他在日本腹膜透析患者中的疗效和安全性。
Ther Apher Dial. 2021 Dec;25(6):979-987. doi: 10.1111/1744-9987.13686. Epub 2021 May 25.
7
Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival.带出口部位更新的导管转流术可提高腹膜透析导管的留存率。
Kidney Int Rep. 2020 Dec 7;6(2):325-332. doi: 10.1016/j.ekir.2020.11.030. eCollection 2021 Feb.
8
Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study.腹膜透析患者结局的预测因素:一项为期 2 年的全国队列研究。
Sci Rep. 2019 Mar 8;9(1):3967. doi: 10.1038/s41598-019-40692-6.